Retinoic acid induction of major histocompatibility complex class I genes in NTera-2 embryonal carcinoma cells involves induction of NF-kappa B (p50-p65) and retinoic acid receptor beta-retinoid X receptor beta heterodimers

Retinoic acid (RA) treatment of human embryonal carcinoma (EC) NTera-2 (NT2) cells induces expression of major histocompatibility complex (MHC) class I and beta-2 microglobulin surface molecules. We found that this induction was accompanied by increased levels of MHC class I mRNA, which was attributable to the activation of the two conserved upstream enhancers, region I (NF-kappa B like) and region II. This activation coincided with the induction of nuclear factor binding activities specific for the two enhancers. Region I binding activity was not present in undifferentiated NT2 cells, but binding of an NF-kappa B heterodimer, p50-p65, was induced following RA treatment. The p50-p65 heterodimer was produced as a result of de novo induction of p50 and p65 mRNAs. Region II binding activity was present in undifferentiated cells at low levels but was greatly augmented by RA treatment because of activation of a nuclear hormone receptor heterodimer composed of the retinoid X receptor (RXR beta) and the RA receptor (RAR beta). The RXR beta-RAR beta heterodimer also bound RA responsive elements present in other genes which are likely to be involved in RA triggering of EC cell differentiation. Furthermore, transfection of p50 and p65 into undifferentiated NT2 cells synergistically activated region I-dependent MHC class I reporter activity. A similar increase in MHC class I reporter activity was demonstrated by cotransfection of RXR beta and RAR beta. These data show that following RA treatment, heterodimers of two transcription factor families are induced to bind to the MHC enhancers, which at least partly accounts for RA induction of MHC class I expression in NT2 EC cells.

[1]  D. McFarlin,et al.  Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. , 1993, Journal of immunology.

[2]  S. Kidd.  Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins , 1992, Cell.

[3]  V. Bours,et al.  The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition , 1992, Nature.

[4]  K. Ozato,et al.  Two upstream elements activate transcription of a major histocompatibility complex class I gene in vitro. , 1992, Nucleic acids research.

[5]  T. Tsukiyama,et al.  Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. , 1992, Molecular and cellular biology.

[6]  R. Evans,et al.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. , 1992, Genes & development.

[7]  P. Dobrzanski,et al.  RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B , 1992, Molecular and cellular biology.

[8]  E. Appella,et al.  H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements. , 1992, Molecular Endocrinology.

[9]  K. Ozato,et al.  Retinoic acid-dependent transactivation of major histocompatibility complex class I promoters by the nuclear hormone receptor H-2RIIBP in undifferentiated embryonal carcinoma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[11]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[12]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[13]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[14]  H. Hamada,et al.  The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. , 1991, The EMBO journal.

[15]  Gary J. Nabel,et al.  Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65 , 1991, Nature.

[16]  S. Weissman,et al.  Identification of cis sequences controlling efficient position-independent tissue-specific expression of human major histocompatibility complex class I genes in transgenic mice , 1991, Molecular and cellular biology.

[17]  A. Israël,et al.  Inhibition of transcription factors belonging to the rel/NF‐kappa B family by a transdominant negative mutant. , 1991, The EMBO journal.

[18]  P. Baeuerle.  The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[19]  P. Sharp,et al.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Bikoff,et al.  Analysis of beta 2-microglobulin gene expression in the developing mouse embryo and placenta. , 1990, Journal of immunology.

[21]  R. Rickles,et al.  Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation , 1990, Molecular and cellular biology.

[22]  Vincent Bours,et al.  Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs , 1990, Nature.

[23]  T. Taniguchi,et al.  Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated , 1990, Cell.

[24]  G. Nolan,et al.  Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal , 1990, Cell.

[25]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[26]  A. Simeone,et al.  Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells , 1990, Nature.

[27]  M. D'Esposito,et al.  Human HOX genes are differentially activated by retinoic acid in embryonal carcinoma cells according to their position within the four loci. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[28]  H. Schöler,et al.  A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes , 1990, Molecular and cellular biology.

[29]  Peter W. J. Rigby,et al.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo , 1990, Nature.

[30]  D. Kulesh,et al.  Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. , 1990, Genes & development.

[31]  M. Karin,et al.  Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription. , 1990, The New biologist.

[32]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[33]  E. Appella,et al.  H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Tjian,et al.  Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. , 1989, Genes & development.

[35]  D. Baltimore,et al.  NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control , 1989, Cell.

[36]  P. Chambon,et al.  Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin , 1989, Nature.

[37]  P. Tucker,et al.  Differential expression of the class I MHC genes in the embryo and placenta during midgestational development in the mouse. , 1989, Journal of immunology.

[38]  E. Appella,et al.  Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene , 1989, The Journal of experimental medicine.

[39]  L. Gudas,et al.  Early retinoic acid-induced F9 teratocarcinoma stem cell gene ERA-1: alternate splicing creates transcripts for a homeobox-containing protein and one lacking the homeobox , 1988, Molecular and cellular biology.

[40]  E. Linney,et al.  Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Miyazaki,et al.  Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells. , 1988, Journal of immunology.

[42]  R. Evans,et al.  Identification of a new class of steroid hormone receptors , 1988, Nature.

[43]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[44]  M. Robertson.  Towards a biochemistry of morphogenesis , 1987, Nature.

[45]  J. Miyazaki,et al.  Binding of multiple nuclear factors to the 5' upstream regulatory element of the murine major histocompatibility class I gene , 1987, Molecular and cellular biology.

[46]  G. Trinchieri,et al.  Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. , 1987, Cancer research.

[47]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[48]  P. Sharp,et al.  Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene , 1987, Molecular and cellular biology.

[49]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[50]  A. Israël,et al.  Detailed analysis of the mouse H-2Kb promoter: Enhancer-like sequences and their role in the regulation of class I gene expression , 1986, Cell.

[51]  K. Ozato,et al.  Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Strickland,et al.  Two-stage hormonal control of type IV collagen mRNA levels during differentiation of F9 teratocarcinoma cells. , 1985, Developmental biology.

[53]  P. Arcari,et al.  The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. , 1984, Nucleic acids research.

[54]  B. Paterson,et al.  alpha-Cardiac actin is the major sarcomeric isoform expressed in embryonic avian skeletal muscle. , 1984, Science.

[55]  P. Chambon,et al.  Structure and expression of the mouse beta 2‐microglobulin gene isolated from somatic and non‐expressing teratocarcinoma cells. , 1983, The EMBO journal.

[56]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[57]  P. Baldacci,et al.  Absence of significant H–2 and β2-microglobulin mRNA expression by mouse embryonal carcinoma cells , 1982, Nature.

[58]  J. Seidman,et al.  Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Adamson,et al.  Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm , 1981, Nature.

[60]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[61]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[62]  K. Artzt,et al.  Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture. , 1974, Transplantation.

[63]  J. Y. Chen,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. , 1992, Cell.

[64]  E. Linney.  Retinoic acid receptors: transcription factors modulating gene regulation, development, and differentiation. , 1992, Current topics in developmental biology.

[65]  T. Maniatis,et al.  A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence. , 1990, Genes & development.

[66]  A. Israël,et al.  The regulation and expression of MHC class I genes. , 1990, Immunology today.

[67]  V. Bours,et al.  A Novel Mitogen-Inducible Gene Product Related to p50/p105-NF-KB Participates in Transactivation through a KB Site , 2022 .